1. Home
  2. Live Updates
  3. Maze therapeutics

Live Breaking News & Updates on Maze Therapeutics|Page 4

Stay updated with breaking news from Maze therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

IQVIA punts on Propel Media, DeepIntent acquisitions after FTC challenge

The temporary block of the deal that was first announced at the tail end of 2022 was ultimately enough to sink IQVIA and DeepIntent’s plans. ....

New York , United States , Henry Liu , Chris Paquette , Bureau Of Competition , Iqvia Holding , Us District Court , Propel Media , Southern District , Federal Trade Commission , Endpoints News , Competition Director Henry Liu , Maze Therapeutics ,

Maze Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) Maze Therapeutics, a company ....

Jason Coloma , Maze Therapeutics , Company Businesswire Health Kbusinesswire Kbusinesswireen Notfrontpage Pressrelease ,

2024 forecast: Biden admin efforts show there's no pricing relief on the horizon for pharma

2024 forecast: Biden admin efforts show there's no pricing relief on the horizon for pharma
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United States , Katie Rubino , Joe Biden , National Institutes Of Health , Boehringer Ingelheim , Inflation Reduction Act , Federal Trade Commission , Maze Therapeutics , President Joe Biden , National Institutes , Steve Ubl , Chad Landmon ,

European Drugmaker Sanofi Ends Tusamitamab Ravtansine Lung Cancer Program After Disappointing Data - Sanofi (NASDAQ:SNY)

Sanofi SA (NASDAQ: SNY) is discontinuing the global clinical development pr ....

Fexinidazole Winthrop , Data Monitoring Committee , Maze Therapeutics Inc , Independent Data Monitoring Committee , Maze Therapeutics , Federal Trade Commission , European Medicines Agency , Medicinal Products , Human Use ,

Illumina to divest Grail, following court's decision to uphold FTC order

Illumina announced it would be divesting cancer test maker Grail, following a battle with antitrust regulators over the $7.1 billion acquisition. ....

Jacob Thaysen , Carl Icahn , Circuit Court , Drug Administration , Federal Trade Commission , Fifth Circuit Court , Maze Therapeutics , Propel Media , Horizon Therapeutics ,